Synonyms |
Arbidol; 6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylic Acid Ethyl Ester |
IUPAC Name |
ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate |
Molecular Weight |
477.41 |
Molecular Formula |
C22H25BrN2O3S |
Canonical SMILES |
CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3 |
InChI |
InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3 |
InChIKey |
KCFYEAOKVJSACF-UHFFFAOYSA-N |
Boiling Point |
591.8±50.0°C (Predicted) |
Flash Point |
311.7±30.1 °C |
Purity |
≥95% |
Density |
1.37±0.1 g/cm3 (Predicted) |
Solubility |
Soluble in Chloroform (Slightly), Methanol (Slightly, Heated) |
Appearance |
Pale Brown to Light Brown Solid |
Storage |
Store at -20°C under inert atmosphere |
Complexity |
546 |
Exact Mass |
476.076904 |
Index Of Refraction |
1.620 |
In Vitro |
Umifenovir exhibits a wide range and potent antiviral activity against a number of viruses including Influenza Viruses A, B and C, respiratory syncytial virus, SARS-CoV, adenovirus, parainfluenza type 5, poliovirus 1, rhinovirus 14, coxsackievirus B5, hantaan virus, Chikungunya virus, HBV and HCV. |
In Vivo |
Umifenovir (25 and 45 mg/ml; p.o.;) shows a survival benefit to mice suffering from influenza infection. Oral administration Result: Increased the survival rate, inhibited the decrease of body weight at 45 mg/mL and inhibited the increase of mice lung index at 25 mg/mL and 45 mg/mL comparing to virus group. |
PSA |
80.00000 |
Target |
Influenza Viruses A, B and C, respiratory syncytial virus, SARS-CoV, adenovirus, parainfluenza type 5, poliovirus 1, rhinovirus 14, coxsackievirus B5, hantaan virus, Chikungunya virus, HBV and HCV |
Vapor Pressure |
0.0±1.7 mmHg at 25°C |
XLogP3-AA |
4.4 |